Molina Healthcare (MOH) was upgraded by Bank of America/Merrill Lynch (BAC) from neutral to buy with a price target of $41 due to strong momentum and tailwinds from health care reform. Shares are higher by about 1.8 percent.
Molina Healthcare (MOH) was upgraded by Bank of America/Merrill Lynch (BAC) from neutral to buy with a price target of $41 due to strong momentum and tailwinds from health care reform. Shares are higher by about 1.8 percent.
